Transient regulation of focal adhesion via Tensin3 is required for nascent oligodendrocyte differentiation

  1. Emeric Merour
  2. Hatem Hmidan
  3. Corentine Marie
  4. Pierre-Henri Helou
  5. Haiyang Lu
  6. Antoine Potel
  7. Jean-Baptiste Hure
  8. Adrien Clavairoly
  9. Yi Ping Shih
  10. Salman Goudarzi
  11. Sebastien Dussaud
  12. philippe Ravassard
  13. Sassan Hafizi
  14. Su Hao Lo
  15. Bassem A Hassan
  16. Carlos Parras  Is a corresponding author
  1. Sorbonne Université, Inserm U1127, CNRS UMR 7225, France
  2. University of California, Davis, United States
  3. University of Portsmouth, United Kingdom

Abstract

The differentiation of oligodendroglia from oligodendrocyte precursor cells (OPCs) to complex and extensive myelinating oligodendrocytes (OLs) is a multistep process that involves largescale morphological changes with significant strain on the cytoskeleton. While key chromatin and transcriptional regulators of differentiation have been identified, their target genes responsible for the morphological changes occurring during OL myelination are still largely unknown. Here, we show that the regulator of focal adhesion, Tensin3 (Tns3), is a direct target gene of Olig2, Chd7, and Chd8, transcriptional regulators of OL differentiation. Tns3 is transiently upregulated and localized to cell processes of immature OLs, together with integrin-b1, a key mediator of survival at this transient stage. Constitutive Tns3 loss-of-function leads to reduced viability in mouse and humans, with surviving knockout mice still expressing Tns3 in oligodendroglia. Acute deletion of Tns3 in vivo, either in postnatal neural stem cells (NSCs) or in OPCs, leads to a two-fold reduction in OL numbers. We find that the transient upregulation of Tns3 is required to protect differentiating OPCs and immature OLs from cell death by preventing the upregulation of p53, a key regulator of apoptosis. Altogether, our findings reveal a specific time window during which transcriptional upregulation of Tns3 in immature OLs is required for OL differentiation likely by mediating integrin-b1 survival signaling to the actin cytoskeleton as OL undergo the large morphological changes required for their terminal differentiation.

Data availability

Sequencing data have been deposited in GEO under accession code GSE203295

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Emeric Merour

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Hatem Hmidan

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Corentine Marie

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Pierre-Henri Helou

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Haiyang Lu

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Antoine Potel

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Jean-Baptiste Hure

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Adrien Clavairoly

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Yi Ping Shih

    Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Salman Goudarzi

    School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Sebastien Dussaud

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5365-8338
  12. philippe Ravassard

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Sassan Hafizi

    School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4539-0888
  14. Su Hao Lo

    Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2675-9387
  15. Bassem A Hassan

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9533-4908
  16. Carlos Parras

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    For correspondence
    carlos.parras@icm-institute.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0248-1752

Funding

National Multiple Sclerosis Society (NMSS RG-1501-02851)

  • Carlos Parras

Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques (ARSEP 2014,2015,2018,2019,2020)

  • Corentine Marie

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were performed according to the guidelines and regulations of the Inserm ethical committees (authorization #A75-13-19) and animal experimentation license A75-17-72

Copyright

© 2022, Merour et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,216
    views
  • 244
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emeric Merour
  2. Hatem Hmidan
  3. Corentine Marie
  4. Pierre-Henri Helou
  5. Haiyang Lu
  6. Antoine Potel
  7. Jean-Baptiste Hure
  8. Adrien Clavairoly
  9. Yi Ping Shih
  10. Salman Goudarzi
  11. Sebastien Dussaud
  12. philippe Ravassard
  13. Sassan Hafizi
  14. Su Hao Lo
  15. Bassem A Hassan
  16. Carlos Parras
(2022)
Transient regulation of focal adhesion via Tensin3 is required for nascent oligodendrocyte differentiation
eLife 11:e80273.
https://doi.org/10.7554/eLife.80273

Share this article

https://doi.org/10.7554/eLife.80273

Further reading

    1. Developmental Biology
    Emily Delgouffe, Samuel Madureira Silva ... Ellen Goossens
    Research Article

    Although the impact of gender-affirming hormone therapy (GAHT) on spermatogenesis in trans women has already been studied, data on its precise effects on the testicular environment is poor. Therefore, this study aimed to characterize, through histological and transcriptomic analysis, the spermatogonial stem cell niche of 106 trans women who underwent standardized GAHT, comprising estrogens and cyproterone acetate. A partial dedifferentiation of Sertoli cells was observed, marked by the co-expression of androgen receptor and anti-Müllerian hormone which mirrors the situation in peripubertal boys. The Leydig cells also exhibited a distribution analogous to peripubertal tissue, accompanied by a reduced insulin-like factor 3 expression. Although most peritubular myoid cells expressed alpha-smooth muscle actin 2, the expression pattern was disturbed. Besides this, fibrosis was particularly evident in the tubular wall and the lumen was collapsing in most participants. A spermatogenic arrest was also observed in all participants. The transcriptomic profile of transgender tissue confirmed a loss of mature characteristics - a partial rejuvenation - of the spermatogonial stem cell niche and, in addition, detected inflammation processes occurring in the samples. The present study shows that GAHT changes the spermatogonial stem cell niche by partially rejuvenating the somatic cells and inducing fibrotic processes. These findings are important to further understand how estrogens and testosterone suppression affect the testis environment, and in the case of orchidectomized testes as medical waste material, their potential use in research.

    1. Computational and Systems Biology
    2. Developmental Biology
    Rachael Kuintzle, Leah A Santat, Michael B Elowitz
    Research Article

    The Notch signaling pathway uses families of ligands and receptors to transmit signals to nearby cells. These components are expressed in diverse combinations in different cell types, interact in a many-to-many fashion, both within the same cell (in cis) and between cells (in trans), and their interactions are modulated by Fringe glycosyltransferases. A fundamental question is how the strength of Notch signaling depends on which pathway components are expressed, at what levels, and in which cells. Here, we used a quantitative, bottom-up, cell-based approach to systematically characterize trans-activation, cis-inhibition, and cis-activation signaling efficiencies across a range of ligand and Fringe expression levels in Chinese hamster and mouse cell lines. Each ligand (Dll1, Dll4, Jag1, and Jag2) and receptor variant (Notch1 and Notch2) analyzed here exhibited a unique profile of interactions, Fringe dependence, and signaling outcomes. All four ligands were able to bind receptors in cis and in trans, and all ligands trans-activated both receptors, although Jag1-Notch1 signaling was substantially weaker than other ligand-receptor combinations. Cis-interactions were predominantly inhibitory, with the exception of the Dll1- and Dll4-Notch2 pairs, which exhibited cis-activation stronger than trans-activation. Lfng strengthened Delta-mediated trans-activation and weakened Jagged-mediated trans-activation for both receptors. Finally, cis-ligands showed diverse cis-inhibition strengths, which depended on the identity of the trans-ligand as well as the receptor. The map of receptor-ligand-Fringe interaction outcomes revealed here should help guide rational perturbation and control of the Notch pathway.